心脏术后静脉-动脉体外膜氧合时机的重要性:一项描述性多中心观察研究
该回顾性多中心观察研究纳入2003例心脏术后休克需ECMO的成人患者,比较术中与术后ECMO的预后。术后ECMO组术前风险更高、并发症更多、住院死亡率更高(64.5% vs 57.5%,P=0.002),但出院后长期生存相似(P=0.86)。
要点
- 术后ECMO组住院死亡率64.5%,高于术中ECMO组的57.5%(P=0.002)。
- 术后ECMO组心脏再手术率24.8%、经皮冠状动脉介入率3.6%,均高于术中组。
- 出院后长期生存两组相似(P=0.86),但术中ECMO组ECMO持续时间更短。
核心结论
- 术中与术后ECMO植入与不同的患者特征和结局相关,术后ECMO并发症更多、住院死亡率更高。
- 需要制定策略以根据特定患者特征确定心脏术后ECMO的最佳地点和时机,以优化住院结局。
研究设计与样本
- 回顾性、多中心、观察性Postcardiotomy Extracorporeal Life Support(PELS-1)研究,纳入2000年至2020年间因心脏术后休克需要ECMO的成人患者。
- 共研究2003例患者(女性41.1%;中位年龄65岁,四分位距55.0-72.0)。
主要发现
- 术中ECMO组(n=1287)与术后ECMO组(n=716)相比,术前风险特征更差。
- 术后ECMO启动的主要指征为心源性休克(45.3%)、右心室衰竭(15.9%)和心脏骤停(14.3%),插管在中位1天(四分位距1-3天)后进行。
- 与术中ECMO相比,术后ECMO患者并发症更多、心脏再手术更多(术中:19.7%;术后:24.8%,P=0.011)、经皮冠状动脉介入更多(术中:1.8%;术后:3.6%,P=0.026),住院死亡率更高(术中:57.5%;术后:64.5%,P=0.002)。
- 在住院存活者中,术中ECMO后ECMO持续时间更短(中位104小时;四分位距67.8-164.2小时),术后ECMO更长(中位139.7小时;四分位距95.8-192小时,P<0.001)。
- 出院后长期生存两组相似(P=0.86)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Postcardiotomy extracorporeal membrane oxygenation (ECMO) can be initiated intraoperatively or postoperatively based on indications, settings, patient profile, and conditions. The topic of implantation timing only recently gained attention from the clinical community. We compare patient characteristics as well as in-hospital and long-term survival between intraoperative and postoperative ECMO. METHODS: The retrospective, multicenter, observational Postcardiotomy Extracorporeal Life Support (PELS-1) study includes adults who required ECMO due to postcardiotomy shock between 2000 and 2020. We compared patients who received ECMO in the operating theater (intraoperative) with those in the intensive care unit (postoperative) on in-hospital and postdischarge outcomes. RESULTS: We studied 2003 patients (women: 41.1%; median age: 65 years; interquartile range [IQR], 55.0-72.0). Intraoperative ECMO patients (n = 1287) compared with postoperative ECMO patients (n = 716) had worse preoperative risk profiles. Cardiogenic shock (45.3%), right ventricular failure (15.9%), and cardiac arrest (14.3%) were the main indications for postoperative ECMO initiation, with cannulation occurring after (median) 1 day (IQR, 1-3 days). Compared with intraoperative application, patients who received postoperative ECMO showed more complications, cardiac reoperations (intraoperative: 19.7%; postoperative: 24.8%, P = .011), percutaneous coronary interventions (intraoperative: 1.8%; postoperative: 3.6%, P = .026), and had greater in-hospital mortality (intraoperative: 57.5%; postoperative: 64.5%, P = .002). Among hospital survivors, ECMO duration was shorter after intraoperative ECMO (median, 104; IQR, 67.8-164.2 hours) compared with postoperative ECMO (median, 139.7; IQR, 95.8-192 hours, P < .001), whereas postdischarge long-term survival was similar between the 2 groups (P = .86). CONCLUSIONS: Intraoperative and postoperative ECMO implantations are associated with different patient characteristics and outcomes, with greater complications and in-hospital mortality after postoperative ECMO. Strategies to identify the optimal location and timing of postcardiotomy ECMO in relation to specific patient characteristics are warranted to optimize in-hospital outcomes.
引用
- Mariani S, Wang IW, van Bussel BCT, et al. The importance of timing in postcardiotomy venoarterial extracorporeal membrane oxygenation: A descriptive multicenter observational study. J Thorac Cardiovasc Surg. 2023. PMID: 37201778. doi:10.1016/j.jtcvs.2023.04.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。